| Angiogenesis after acute myocardial infarction X Wu, MR Reboll, M Korf-Klingebiel, KC Wollert Cardiovascular research 117 (5), 1257-1273, 2021 | 278 | 2021 |
| Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial X Huo, HM Krumholz, X Bai, ES Spatz, Q Ding, P Horak, W Zhao, Q Gong, ... Circulation: Cardiovascular Quality and Outcomes 12 (9), e005805, 2019 | 83 | 2019 |
| Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial X Zheng, ES Spatz, X Bai, X Huo, Q Ding, P Horak, X Wu, W Guan, ... Circulation: Cardiovascular Quality and Outcomes 12 (4), e005616, 2019 | 60 | 2019 |
| Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase MR Reboll, S Klede, MH Taft, CL Cai, LJ Field, KJ Lavine, AL Koenig, ... Science 376 (6599), 1343-1347, 2022 | 57 | 2022 |
| Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression … M Korf-Klingebiel, MR Reboll, F Polten, N Weber, F Jäckle, X Wu, ... Circulation 144 (15), 1227-1240, 2021 | 49 | 2021 |
| Heparan sulfate–editing extracellular sulfatases enhance VEGF bioavailability for ischemic heart repair M Korf-Klingebiel, MR Reboll, K Grote, H Schleiner, Y Wang, X Wu, ... Circulation research 125 (9), 787-801, 2019 | 47 | 2019 |
| Traditional Chinese medicine for acute myocardial infarction in western medicine hospitals in China ES Spatz, Y Wang, AL Beckman, X Wu, Y Lu, X Du, J Li, X Xu, ... Circulation: Cardiovascular Quality and Outcomes 11 (3), e004190, 2018 | 30 | 2018 |
| Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target H Zhang, PN Thai, RV Shivnaraine, L Ren, X Wu, DH Siepe, Y Liu, C Tu, ... Cell 187 (25), 7143-7163. e22, 2024 | 5 | 2024 |
| Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: A randomized clinical trial. Circulation. Cardiovascular … X Huo, HM Krumholz, X Bai, ES Spatz, Q Ding, P Horak, W Zhao, Q Gong, ... | 5 | 2019 |
| Heparan sulfate-editing extracellular sulfatases enhance vascular endothelial growth factor bioavailability for ischemic heart repair M Korf-Klingebiel, MR Reboll, K Grote, H Schleiner, Y Wang, X Wu, ... Circulation research 125 (9), 2019 | 5 | 2019 |
| Clinical trials in-a-dish for cardiovascular medicine X Wu, K Swanson, Z Yildirim, W Liu, R Liao, JC Wu European Heart Journal, ehae519, 2024 | 4 | 2024 |
| Next-Gen therapeutics: Pioneering drug discovery with iPSCs, genomics, AI, and clinical trials in a dish Z Yildirim, K Swanson, X Wu, J Zou, J Wu Annual Review of Pharmacology and Toxicology 65 (2025), 71-90, 2025 | 3 | 2025 |
| Effect of Cardiovascular Health and Text Messaging (CHAT) on Risk Factor Management in Patients with Coronary Heart Disease: A Randomized Clinical Trial X Zheng, ES Spatz, X Bai, X Huo, Q Ding, P Horak, X Wu, W Guan, ... Circulation: Cardiovascular Quality and Outcomes 12 (Suppl_1), A293-A293, 2019 | 3 | 2019 |
| Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repair X Wu, L Zheng, MR Reboll, LF Hyde, E Mass, HW Niessen, M Kosanke, ... Nature Cardiovascular Research 3 (2), 186-202, 2024 | 1 | 2024 |
| Lnc-ing epicardium-derived cells to cardiac remodelling: lncRNA-TARID as a novel antifibrotic option X Wu, F Vacante, JC Wu European Heart Journal 44 (19), 1761-1763, 2023 | 1 | 2023 |
| Myeloid-derived Growth Factor Ameliorates Cardiac Fibrosis Via Shedding TGFBR1 in Fibroblasts X Wu Medizinische Hochschule Hannover, 2022 | | 2022 |
| Application and Affecting Factor Analysis of Clopidogrel Loading Therapy in STEMI Patients With Percutaneous Coronary Intervention in China in 2006 and 2011 X WU, L Zhang, X Zheng, M SU, J Liu, H Zhang, X Bai, X LI, L Jiang Chinese Circulation Journal, 432-436, 2016 | | 2016 |